AMCP Science & Innovation Webinars
AMCP’s Science & Innovation Webinars provide an opportunity for companies and organizations to increase awareness and visibility by presenting on topics or issues to a focused audience of managed care professionals. Webinars are conducted live. If the sponsoring company allows, the webinar recording is then posted to AMCP's Resource Center for additional exposure and serving as an additional tool for your Market Access team and others.
2021 Science & Innovation Webinar Statistics:
- Registration Average: 90, Registration Range: 40-190
- Attendance Average: 60, Attendance Range: 15-120
- While attendees do vary by topic, on average over 35% work for health plans or PBMs
Please Note: In addition to some very niche and rare disease topics, the number of webinars doubled between 2020 and 2021.
This opportunity is limited to AMCP Corporate Members Only. Cost is $17,500 each.
If you are interested in AMCP developing a webinar for you through our education department, contact View Email Address.
AMCP PIE Webinars
Per the Food and Drug Administration’s (FDA) 2018 Final Guidance Document, preapproval information exchange (PIE) allows manufacturers to proactively share information with eligible healthcare decision makers (ie, payers, formulary committees, and similar entities) about products and devices that are not yet FDA-approved/cleared for use and/or unapproved uses.
AMCP PIE webinars create an opportunity to share preapproval information with healthcare decision makers to help plan for future approvals and associated early product reviews, coverage and reimbursement decisions, and budget forecasting.
Research conducted by FormularyDecisions® in 2021 found that 74% of surveyed FormularyDecisions users (N=23) reported that their organization used preapproval information in formulary decision making. Additionally, 83% reported that their organization had experience using preapproval information.
FormularyDecisions Survey Results (2021)
The AMCP PIE webinar offers opportunities for flexible scheduling throughout the year and uses FormularyDecisions to verify eligible registrants who review scientific and/or technology assessments to make drug or device selection or acquisition, formulary management, and/or coverage and reimbursement decisions on a population basis. Eligible participants include the following:
- Public and private sector payers (eg, third-party payers, health plan sponsors, state Medicaid programs, Medicare programs)
- Formulary committees (eg, Pharmacy and Therapeutics Committees)
- Drug information centers and technology assessment committees
- Pharmacy benefit managers and third-party administrators
- Other multidisciplinary entities (eg, integrated delivery networks, hospitals, and health systems)
FormularyDecisions connects US healthcare decision makers to peer community opinions, access to evidence-based resources, and bi-directional communication exchange opportunities with life sciences manufacturers. If you are a healthcare decision maker and would like to access all webinars, evidence, and tools in FormularyDecisions, register here.
You can also learn more about FormularyDecisions by visiting our website. FormularyDecisions will verify your registration status as a healthcare decision maker before allowing access to content and services.
Please contact View Email Address for assistance with registering and a team member will be in touch.
Disclaimer: These webinars are only offered to healthcare decision makers, formulary committees, or other similar entities responsible for selecting healthcare products for coverage or reimbursement. By registering/joining a webinar, you agree not to copy or disseminate any of the information to individuals not approved to receive the information by the FDA Final Guidance document. You also agree that the information shared with you is to be used for the purposes of evaluating products for formulary placement/utilization management and may not be used by you or your company for any other purpose.You also agree to share the details specified below with the company holding the webinar, for the purpose of evaluating your eligibility to attend the webinar; contacting you as per the company’s compliance regulations, should any information presented change; or in response to a question posed during the webinar. The company may also contact you if you registered for the webinar but did not attend. The details that will be shared are first name, last name, company name, professional degree, position, role, and employer-provided email address.